0001477932-24-001895.txt : 20240405
0001477932-24-001895.hdr.sgml : 20240405
20240405161949
ACCESSION NUMBER: 0001477932-24-001895
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240405
DATE AS OF CHANGE: 20240405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALLIGAN JOSEPH J
CENTRAL INDEX KEY: 0001198613
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54208
FILM NUMBER: 24826773
MAIL ADDRESS:
STREET 1: 333 SOUTH GRAND AVENUE, 18TH FLOOR
CITY: LOS ANGELES
STATE: CA
ZIP: 90071
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioCorRx Inc.
CENTRAL INDEX KEY: 0001443863
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 900967447
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2390 EAST ORANGEWOOD AVENUE
STREET 2: SUITE 500
CITY: ANAHEIM
STATE: CA
ZIP: 92806
BUSINESS PHONE: (714) 462-4880
MAIL ADDRESS:
STREET 1: 2390 EAST ORANGEWOOD AVENUE
STREET 2: SUITE 500
CITY: ANAHEIM
STATE: CA
ZIP: 92806
FORMER COMPANY:
FORMER CONFORMED NAME: FRESH START PRIVATE MANAGEMENT, INC.
DATE OF NAME CHANGE: 20101115
FORMER COMPANY:
FORMER CONFORMED NAME: Cetrone Energy CO
DATE OF NAME CHANGE: 20080826
4
1
form4.xml
FORM 4
X0508
4
2024-01-02-05:00
false
0001443863
BioCorRx Inc.
BICX
0001198613
GALLIGAN JOSEPH J
2390 EAST ORANGEWOOD
SUITE 500
ANAHEIM
CA
92806
true
false
true
false
false
Common Stock, par value $0.001
2024-01-02-05:00
4
A
false
6173
0
A
232292
D
Common Stock, par value $0.001
2024-03-28-05:00
4
A
false
5566
0
A
237858
D
These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81.
These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90.
/s/ Joseph J. Galligan
2024-04-05-05:00